WHO calls for Expressions of Interest in developing Sabin-IPV

Safe and affordable inactivated polio vaccine for low-income countries

The World Health Organization’s Global Polio Eradication Initiative (WHO/POL) is looking for Expressions of Interest from private or public sector vaccine manufacturers in developing countries interested in collaborating with WHO and Intravacc in the development, manufacture and distribution of a safe effective and affordable Sabin Inactivated Polio Vaccine (sIPV), that can be produced securely in developing country settings.

Related


Related News

   07/05/2020
Dr Peter Brauer, a polio survivor and expert on treatment of Post-Polio Syndrome (PPS), illustrates his personal experiences in a moving and beautiful poem.
   29/04/2020
A reminder of why vaccines are so important.
   22/01/2020
Exploring the ‘plus’ in PolioPlus.
   18/09/2019
Form by form, campaign by campaign, data handlers like Jan, Ali, and Bilal are helping to end polio.
   12/09/2019
In Mogadishu, the capital of Somalia, dedicated environmental surveillance teams search for the poliovirus in the city’s drains.
   10/09/2019
UAE, partners, and donors in attendance as Global Polio Eradication Initiative introduces 2019-2023 Investment Case